Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 6Breast Neoplasms 4Prostatic Neoplasms 3Lung Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Disease 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 1Osteosarcoma 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Histologically-confirmed Malignancies 1Hepatic Malignancies 1Hematologic Neoplasms 1Glioma 1Glioblastoma 1Febrile Neutropenia 1Esophageal Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma, Hepatocellular 1

Interventions

zirconium-89-trastuzumab 1Positron Emission Tomography Computed Tomography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Breast Cancer Metastases × Positron Emission Tomography Computed Tomography × Clear all
NCT02286843 2021-06-18

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

Memorial Sloan Kettering Cancer Center

Phase NA Completed
49 enrolled 8 charts
Breast

Breast Cancer Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡